JK
Jwala Kumar Singh
About Jwala Kumar Singh
Data last updated:
Jwala Kumar Singh is a Director at Hillon Pharmaceuticals Private Limited (since 2017). The companies operate in Trading. Hillon Pharmaceuticals Private Limited reported revenue of ₹38.7 Lakh (FY 2024). Earlier, Jwala Kumar Singh was a Director at Paceone Global Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Aug 2017 | 2017 | ₹38.7 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Nov 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jwala Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Kumar Singh | 07887981 | Hillon Pharmaceuticals Private Limited | Director |
| Pankaj Kumar | 08819765 | Hillon Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jwala Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jwala Kumar Singh
Jwala Kumar Singh currently holds 1 directorship: Hillon Pharmaceuticals Private Limited (Director, since 07 Aug 2017, revenue ₹38.7 Lakh (FY 2024)).
Jwala Kumar Singh was first appointed on 07 Aug 2017 as Director at Hillon Pharmaceuticals Private Limited. The most recent appointment on record is 14 Nov 2019 at Paceone Global Private Limited.
Jwala Kumar Singh held 1 earlier board appointment: Paceone Global Private Limited (Director, from 14 Nov 2019).
The current boards of Jwala Kumar Singh's companies include Deepak Kumar Singh (Hillon Pharmaceuticals Private Limited), Pankaj Kumar (Hillon Pharmaceuticals Private Limited).